Clinical trial
Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone…
NCT00480649 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00480649 |
|---|---|
| Title | Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS) |
| Official title | SUccessful Control and Clinical Effectiveness of SERETIDE Study in aSthma, a Randomised Controlled Study to Investigate the Clinical Effectiveness and Health Outcome of SERETIDE in Patients With Moderate and Severe Persistent Asthma in Korea |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Salmeterol/ fluticasone propionate |
| Enrollment | 424 |
| Start date | Jan 1, 2004 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | May 31, 2007 |
| Last update posted | Nov 12, 2012 |
| Countries | South Korea |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: